|
51
|
Pharm/tox |
藥品生殖發育毒性檢測指導原則
|
2021-11-22 |
|
52
|
Product specific BE guideline |
Abiraterone acetate tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
53
|
Product specific BE guideline |
Amlodipine + Atorvastatin tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
54
|
Product specific BE guideline |
Azacitidine Lyophilized Powder for Injection_生體相等性試驗指導原則
|
2021-11-22 |
|
55
|
Product specific BE guideline |
Deferasirox Tablet for suspension_生體相等性試驗指導原則
|
2021-11-22 |
|
56
|
Product specific BE guideline |
Dutasteride capsule_生體相等性試驗指導原則
|
2021-11-22 |
|
57
|
Product specific BE guideline |
Esomeprazole magnesium delayed release tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
58
|
Product specific BE guideline |
Gefitinib Tablet _生體相等性試驗指導原則
|
2021-11-22 |
|
59
|
Product specific BE guideline |
Imatinib Mesylate Tablets_生體相等性試驗指導原則
|
2021-11-22 |
|
60
|
Product specific BE guideline |
Lidocaine Prilocaine_生體相等性試驗指導原則
|
2021-11-22 |
